Meyers Michael L.
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Meyers Michael L.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NUVL | Award / Grant | 2,647 | — | — | Jun 18, 2025 | |
| NUVL | Award / Grant | 2,499 | — | — | Jun 12, 2024 | |
| SNDX | SVP, Chief Medical Officer | Other | 1,714 | $12.39 | $21,236 | Jan 31, 2022 |
| SNDX | SVP, Chief Medical Officer | Option Exercise | 5,900 | $8.77 | $51,743 | Dec 30, 2021 |
| SNDX | SVP, Chief Medical Officer | Purchase | 500 | $15.46 | $7,730 | Apr 26, 2021 |
| SNDX | SVP, Chief Medical Officer | Other | 1,771 | $12.00 | $21,252 | Jul 31, 2020 |
| SNDX | SVP, Chief Medical Officer | Award / Grant | 3,500 | — | — | Jul 6, 2020 |
| SNDX | SVP, Chief Medical Officer | Purchase | 8 | $4.87 | $39 | Mar 21, 2019 |
| SNDX | SVP, Chief Medical Officer | Purchase | 104 | $4.87 | $506 | Mar 21, 2019 |
| SNDX | SVP, Chief Medical Officer | Other | 3,720 | $4.76 | $17,707 | Jan 31, 2019 |
| SNDX | SVP, Chief Medical Officer | Purchase | 200 | $4.79 | $958 | Oct 30, 2018 |